At the beginning of the next year, the data of the third phase of the vaccine trials will be available. Currently, it is developed only after it the decision about the vaccination will be made. The experts added that the current results of the trials give hope and a few pharmaceutical groups will produce millions of doses for vaccination.
It is planned to vaccinate people from the groups of risk first. The decision about the priority of the vaccination will also depend on the characteristics of the vaccines. They are based on different pharmacological guidelines and they might be ineffective for older people.
The United Nations Children's Fund (UNICEF) announced the beginning of the preparation for the large-scale operation on procurement and supply of the vaccines against coronavirus. Until the end of 2020, the fund plans to put over a half billion of syringes in their warehouses.
“By the end of the year, we will already have over half a billion syringes pre-positioned where they can be deployed quickly and cost-effectively,” UNICEF Head Henrietta Fore said.
It is noted that in 2021, UNICEF plans to provide the supply of half a billion syringes for immunization against coronavirus – besides 620 million syringes for vaccination against measles, typhoid and more.
“Vaccinating the world against COVID-19 will be one of the largest mass undertakings in human history, and we will need to move as quickly as the vaccines can be produced. In order to move fast later, we must move fast now,” Fore noted.
As we reported, more than 180 countries pledged to participate in the World Health Organization (WHO) COVAX program to fund Covid-19 vaccines, which will be distributed fairly in both rich and poor countries.
Besides, the WHO stated that due to the limited number of vaccines, it is planned to use it sparingly that is why young and healthy people should wait until 2022.